Evidence for κ- and μ-opioid receptor expression in C6 glioma cells

Journal of Neurochemistry

Volumn 70, Issue 5, 1998, Pages 1819-1825

  Bohn, Laura M ^a   Belcheva, Mariana M ^a   Coscia, Carmine J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C6 glioma; Desipramine; Morphine; Opioid receptor; PCR; U69,593; Endorphin

Indexed keywords

BETA ENDORPHIN; DESIPRAMINE; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE;

ANIMAL CELL; ARTICLE; ASTROCYTOMA; CALCIUM MOBILIZATION; CELL PROLIFERATION; CELL TRANSFORMATION; CROSS LINKING; DNA SYNTHESIS; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GLIOMA CELL; LIGAND BINDING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0031958695     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70051819.x     Document Type: Article

References (48)

1. Albouz S., Tocque B., Hauw J. J., Boutry J. M., LeSaux F., Bourdoin R., and Baumann N. (1982) Tricyclic antidepressant desipramine induces stereospecific opiate binding and lipid modification in rat glioma C6 cells. Life Sci. 31, 2549-2554.
2. Avidor-Reiss T., Nevo I., Levy R., Pfeuffer T., and Vogel Z. (1996) Chronic opioid treatment induces adenylyl cyclase V superactivation. J. Biol. Chem. 271, 21309-21315.
3. Bare L. A., Mansson E., and Yang D. (1994) Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354, 213-216.
4. Barg J., Belcheva M., Bem W. T., Lambourne B., McLachlan J. A., Tolman K. C., Johnson F. E., and Coscia C. J. (1991) Desipramine modulation of sigma and opioid peptide receptor expression in glial cells. Peptides 12, 845-849.
5. Barg J., Belcheva M. M., and Coscia C. J. (1992) Evidence for the implication of phosphoinositol signal transduction in μ-opioid inhibition of DNA synthesis. J. Neurochem. 59, 1145-1152.
6. 3H-thymidine incorporation into DNA: evidence for the involvement of pertussis toxin-sensitive G protein-coupled phosphoinositide turnover. J. Neurochem. 60, 1505-1511.
7. Barg J., Belcheva M. M., McHale R. J., Levy R., Vogel Z., and Coscia C. J. (1993b) β-Endorphin is a potent inhibitor of thymidine incorporation into DNA via μ-and κ-opioid receptors in fetal rat brain cell aggregates in culture. J. Neurochem. 60, 765-767.
8. Barg J., Belcheva M. M., Levy R., McHale R. J., McLachlan J. A., Johnson F. E., Vogel Z., and Coscia C. J. (1994a) A monoclonal anti-idiotypic antibody to opioid receptors labels desipramine-induced opioid binding sites on rat C6 glioma cells and attenuates thymidine incorporation into DNA. Glia 10, 10-15.
9. 2+ mobilization in rat C6 glioma cells. J. Neurosci. 14, 5858-5864.
10. Bartolome J. V., Bartolome M. B., Lorber B., Dileo S., and Schanberg S. (1991) Effects of central administration of beta-endorphin on brain and liver DNA synthesis in preweanling rats. Neuroscience 40, 289-294.
11. Belcheva M. M., Ignatova E. G., Young E. C., and Coscia C. J. (1996a) Agonist-induced desensitization and down-regulation of δ opioid receptors alter the levels of their I-125-β-endorphin cross-linked products in subcellular fractions from NG108-15 cells. Biochemistry 35, 14818-14824.
12. Belcheva M. M., Ho M. T., Ignatova E., Jefcoat L. B., Barg J., Vogel Z., McHale R. J., Johnson F. E., and Coscia C. J. (1996b) Buprenorphine differentially alters opioid receptor adaptation in rat brain regions. J. Pharmacol. Exp. Ther. 277, 1322-1327.
13. Blumer K. J. and Johnson G. L. (1994) Diversity in function and regulation of MAP kinase pathways. Trends Biochem. Sci. 19, 236-240.
14. Bunn S. J., Hanley M. R., and Wilkin G. P. (1985) Evidence for a kappa-opioid receptor on pituitary astrocytes: an autoradiographic study. Neurosci. Lett. 55, 317-323.
15. Chao C. C., Gekker G., Hu S., Sheng W. S., Shark K. B., Bu D. F., Archer S., Bidlack J. M., and Peterson P. K. (1996) Kappa opioid receptors in human microglia downregulate human immunodeficiency virus 1 expression. Proc. Natl. Acad. Sci. USA 93, 8051-8056.
16. Chen C., Xue J.-C., Zhu J., Chen Y.-W., Kunapuli S., Kim de Riel J., Yu L., and Liu-Chen L.-Y. (1995) Characterization of irreversible binding of β-funaltrexamine to the cloned rat μ opioid receptor. J. Biol. Chem. 270, 17866-17870.
17. 3 subtype. J. Pharmacol. Exp. Ther. 251, 461-468.
18. Craves F. B., Zalc B., Leybin L., Baumann N., and Loh H. H. (1980) Antibodies to cerebroside sulfate inhibit the effects of morphine and beta-endorphin. Science 207, 75-76.
19. 3 receptor with selectivity for opiate alkaloids but without affinity for opioid peptides. Brain Res. 667, 229-237.
20. 3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res. 686, 239-248.
21. Eriksson P. S., Hansson E., and Ronnback L. (1990) δ and κ opiate receptors in primary astroglial cultures from rat cerebral cortex. Neurochem. Res. 15, 1123-1126.
22. Fukuda K., Kato S., Mori K., Nishi M., and Takeshima H. (1993) Primary structures and expression from cDNAs of rat opioid receptor delta-and mu-subtypes. FEBS Lett. 327, 311-314.
23. Gavériaux C., Peluso J., Simonin F., Laforet J., and Kieffer B. (1995) Identification of κ-and δ-opioid receptor transcripts in immune cells. FEBS Lett. 369, 272-276.
24. Gavériaux-Ruff C., Peluso J., Befort K., Simonin F., Zilliox C., and Kieffer B. L. (1997) Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the delta-and kappa-opioid receptors. Mol. Brain Res. 48, 298-304.
25. 2+ mobilization, development, and the antiproliferative effect of opioids. Brain Res. 737, 175-187.
26. Hammer R. and Hauser K. (1992) Consequences of early exposure to opioids on cell proliferation and neuronal morphogenesis, in Development of the Central Nervous System: Effects of Alcohol and Opiates (Miller M. W., ed), pp. 319-339. Wiley-Liss, New York.
27. 2+-dependent mechanism. Brain Res. 720, 191-203.
28. Howard A. D., deLa Baume S., Gioannini T. L., Hiller J. M., and Simon E. J. (1985) Covalent labeling of opioid receptors with radioiodinated human β-endorphin. J. Biol. Chem. 260, 10833-10839.
29. Johannesson T., Steele W. J., and Becker B. A. (1972) Infusion of morphine in maternal rats at near-term: maternal and foetal distribution and effects on analgesia, brain DNA, RNA, and protein. Acta Pharmacol. Toxicol. 31, 353-368.
30. Kettenmann H. and Ransom B. R. (1995) Neuroglia. Oxford University Press, Oxford.
31. Kornblum H., Loughlin S., and Leslie F. (1987) Effects of morphine on DNA synthesis in neonatal rat brain. Dev. Brain Res. 31, 45-52.
32. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
33. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
34. Parker K., Norenberg M., and Vernadakis A. (1980) "Transdifferentiation" of C6 glial cells in culture. Science 208, 179-181.
35. Reggiani A., Carenzi A., and Della Bella D. (1986) Opioid and β-receptor interactions: further studies in cultured cells. NIDA Res. Monogr. 75, 347-350.
36. 6 glioma cells. Brain Res. 423, 254-260.
37. Rothman R., Bykov V., Costa B., Arthur J., Rice K., and Brady L. (1990) Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides 11, 311-331.
38. Ruzicka B. B., Fox C. A., Thompson R. C., Meng F., Watson S. J., and Akil H. (1995) Primary astroglial cultures derived from several rat brain regions differentially express mu, delta and kappa opioid receptor mRNA. Mol. Brain Res. 34, 209-220.
39. Schwartz J. P. and Taniwaki T. (1994) Heterogeneity of expression of neuropeptide genes by astrocytes: functional implications. Perspect. Dev. Neurobiol. 2, 251-257.
40. 125I]β-endorphin binding to NG108-15 and SK-N-SH cell membranes: specific cation requirements. Brain Res. 493, 23-32.
41. Stiene-Martin A. and Hauser K. F. (1991) Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro. J. Neurosci. Res. 29, 538-548.
42. Thompson R. C., Mansour A., Akil H., and Watson S. J. (1993) Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 11, 903-913.
43. 6 glioma cells. J. Neurochem. 42, 1101-1106.
44. 5-enkephalinamide treatment on the DNA synthesis in the developing rat brain. Life Sci. 31, 119-126.
45. Zadina J. E., Hackler L., Ge L. J., and Kastin A. J. (1997) A potent and selective endogenous agonist for the mu-opiate receptor. Nature 386, 499-502.
46. Zagon I. S. and McLaughlin P. J. (1983) Increased brain size and cellular content in infant rats treated with an opiate antagonist. Science 221, 1179-1180.
47. Zagon I. S. and McLaughlin P. J. (1991) Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res. 542, 318-323.
48. Zimprich A., Simon T., and Hollt V. (1995) Cloning and expression of an isoform of the rat mu opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359, 142-146.